Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$135.05 - $182.59 $1.46 Million - $1.98 Million
-10,830 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$145.58 - $192.14 $207,597 - $273,991
-1,426 Reduced 11.64%
10,830 $1.58 Million
Q2 2021

Aug 10, 2021

BUY
$134.22 - $202.37 $1.65 Million - $2.48 Million
12,256 New
12,256 $2.4 Million
Q4 2020

Feb 12, 2021

SELL
$126.47 - $163.7 $3.16 Million - $4.09 Million
-25,005 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$87.44 - $125.0 $2.19 Million - $3.13 Million
25,005 New
25,005 $3.12 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.